Literature DB >> 26269193

The role for gut permeability in the pathogenesis of type 1 diabetes--a solid or leaky concept?

Xia Li1, Mark A Atkinson2.   

Abstract

Increasing evidence, both functional and morphological, supports the concept of increased intestinal permeability as an intrinsic characteristic of type 1 diabetes (T1D) in both humans and animal models of the disease. Often referred to as a 'leaky gut', its mechanistic impact on the pathogenesis of T1D remains unclear. Hypotheses that this defect influences immune responses against antigens (both self and non-self) predominate, yet others argue hyperglycemia and insulitis may contribute to increased gut permeability in T1D. To address these complicated issues, we herein review the many conceptual role(s) for a leaky gut in the pathogenesis of T1D and suggest ways that if true, therapeutic interventions aimed at the gut-pancreas axis may prove promising for future therapeutic interventions.
© 2015 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  barrier function diabetes; beta-cell autoimmunity; intestinal permeability

Mesh:

Substances:

Year:  2015        PMID: 26269193      PMCID: PMC4638168          DOI: 10.1111/pedi.12305

Source DB:  PubMed          Journal:  Pediatr Diabetes        ISSN: 1399-543X            Impact factor:   4.866


  63 in total

1.  Role of the intestinal tight junction modulator zonulin in the pathogenesis of type I diabetes in BB diabetic-prone rats.

Authors:  Tammara Watts; Irene Berti; Anna Sapone; Tania Gerarduzzi; Tarcisio Not; Ronald Zielke; Alessio Fasano
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-14       Impact factor: 11.205

Review 2.  Does the gut microbiota have a role in type 1 diabetes? Early evidence from humans and animal models of the disease.

Authors:  M A Atkinson; A Chervonsky
Journal:  Diabetologia       Date:  2012-08-09       Impact factor: 10.122

3.  Butyrate and type 1 diabetes mellitus: can we fix the intestinal leak?

Authors:  Nan Li; Marguerite Hatch; Clive H Wasserfall; Martha Douglas-Escobar; Mark A Atkinson; Desmond A Schatz; Josef Neu
Journal:  J Pediatr Gastroenterol Nutr       Date:  2010-10       Impact factor: 2.839

Review 4.  Leaky gut and diabetes mellitus: what is the link?

Authors:  S de Kort; D Keszthelyi; A A M Masclee
Journal:  Obes Rev       Date:  2011-03-08       Impact factor: 9.213

Review 5.  Zonulin and its regulation of intestinal barrier function: the biological door to inflammation, autoimmunity, and cancer.

Authors:  Alessio Fasano
Journal:  Physiol Rev       Date:  2011-01       Impact factor: 37.312

Review 6.  Insulin-dependent diabetes and gut dysfunction: the BB rat model.

Authors:  W J Malaisse; P Courtois; F W Scott
Journal:  Horm Metab Res       Date:  2004-09       Impact factor: 2.936

Review 7.  Intestinal permeability and its regulation by zonulin: diagnostic and therapeutic implications.

Authors:  Alessio Fasano
Journal:  Clin Gastroenterol Hepatol       Date:  2012-08-16       Impact factor: 11.382

8.  Four weeks of treatment with liraglutide reduces insulin dose without loss of glycemic control in type 1 diabetic patients with and without residual beta-cell function.

Authors:  Urd Kielgast; Thure Krarup; Jens Juul Holst; Sten Madsbad
Journal:  Diabetes Care       Date:  2011-05-18       Impact factor: 19.112

9.  Innate immunity and intestinal microbiota in the development of Type 1 diabetes.

Authors:  Li Wen; Ruth E Ley; Pavel Yu Volchkov; Peter B Stranges; Lia Avanesyan; Austin C Stonebraker; Changyun Hu; F Susan Wong; Gregory L Szot; Jeffrey A Bluestone; Jeffrey I Gordon; Alexander V Chervonsky
Journal:  Nature       Date:  2008-09-21       Impact factor: 49.962

10.  Small intestinal permeability in older adults.

Authors:  Luzia Valentini; Sara Ramminger; Verena Haas; Elisa Postrach; Martina Werich; André Fischer; Michael Koller; Alexander Swidsinski; Stefan Bereswill; Herbert Lochs; Jörg-Dieter Schulzke
Journal:  Physiol Rep       Date:  2014-04-22
View more
  40 in total

Review 1.  Blood-based signatures in type 1 diabetes.

Authors:  Susanne M Cabrera; Yi-Guang Chen; William A Hagopian; Martin J Hessner
Journal:  Diabetologia       Date:  2015-12-23       Impact factor: 10.122

Review 2.  Antibiotics, gut microbiota, environment in early life and type 1 diabetes.

Authors:  Youjia Hu; F Susan Wong; Li Wen
Journal:  Pharmacol Res       Date:  2017-02-07       Impact factor: 7.658

Review 3.  The "Gut Feeling": Breaking Down the Role of Gut Microbiome in Multiple Sclerosis.

Authors:  Samantha N Freedman; Shailesh K Shahi; Ashutosh K Mangalam
Journal:  Neurotherapeutics       Date:  2018-01       Impact factor: 7.620

Review 4.  Zonulin as a potential putative biomarker of risk for shared type 1 diabetes and celiac disease autoimmunity.

Authors:  Lauren K Wood Heickman; Mark D DeBoer; Alessio Fasano
Journal:  Diabetes Metab Res Rev       Date:  2020-03-31       Impact factor: 4.876

Review 5.  Early-life factors contributing to type 1 diabetes.

Authors:  Maria E Craig; Ki Wook Kim; Sonia R Isaacs; Megan A Penno; Emma E Hamilton-Williams; Jennifer J Couper; William D Rawlinson
Journal:  Diabetologia       Date:  2019-08-27       Impact factor: 10.122

Review 6.  Intestinal dysbiosis and probiotic applications in autoimmune diseases.

Authors:  Gislane Lelis Vilela de Oliveira; Aline Zazeri Leite; Bruna Stevanato Higuchi; Marina Ignácio Gonzaga; Vânia Sammartino Mariano
Journal:  Immunology       Date:  2017-06-29       Impact factor: 7.397

Review 7.  Gut-derived low-grade endotoxaemia, atherothrombosis and cardiovascular disease.

Authors:  Francesco Violi; Vittoria Cammisotto; Simona Bartimoccia; Pasquale Pignatelli; Roberto Carnevale; Cristina Nocella
Journal:  Nat Rev Cardiol       Date:  2022-07-15       Impact factor: 49.421

8.  The Gut Mucosal Firewall and Functional Medicine.

Authors:  Jeffrey Bland
Journal:  Integr Med (Encinitas)       Date:  2016-08

9.  Mucosal immunity-mediated modulation of the gut microbiome by oral delivery of probiotics into Peyer's patches.

Authors:  Sisi Lin; Subhajit Mukherjee; Juanjuan Li; Weiliang Hou; Chao Pan; Jinyao Liu
Journal:  Sci Adv       Date:  2021-05-12       Impact factor: 14.136

Review 10.  FFAR from the Gut Microbiome Crowd: SCFA Receptors in T1D Pathology.

Authors:  Medha Priyadarshini; Kristen Lednovich; Kai Xu; Sophie Gough; Barton Wicksteed; Brian T Layden
Journal:  Metabolites       Date:  2021-05-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.